Best-practice guidelines in assessment, risk reduction, management, and surveillance for post-breast cancer lymphedema

Jane M. Armer, Jennifer M. Hulett, Michael J Bernas, Pam Ostby, Bob R. Stewart, Janice N. Cormier

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Breast cancer-related lymphedema (LE) is a progressive, chronic disease that affects millions of cancer survivors and primarily results from surgical lymphatic vessel and/or node removal and radiation therapy. Patient support and education in the importance of early detection is essential in helping health care providers detect lymphedema early, when there is the best chance of preventing progression. Improved imaging and surgical techniques have reduced the incidence of LE; however, effective risk-reduction and treatment have historically lacked the level of evidence necessary to standardize effective treatment. The purpose of this article is to report an extensive review of literature, including highlighted multidisciplinary studies within the past 3 years, in order to update best-practice guidelines in assessment, risk reduction, management, and surveillance for post-breast cancer lymphedema.

Original languageEnglish (US)
Pages (from-to)134-144
Number of pages11
JournalCurrent Breast Cancer Reports
Volume5
Issue number2
DOIs
StatePublished - Jun 2013

Fingerprint

Lymphedema
Risk Management
Risk Reduction Behavior
Practice Guidelines
Lymphatic Vessels
Patient Education
Health Personnel
Survivors
Chronic Disease
Radiotherapy
Incidence
Therapeutics
Neoplasms
Breast Cancer Lymphedema

Keywords

  • Breast cancer
  • Combined decongestive therapy
  • Complementary
  • Compression garment
  • Exercise
  • Intermittent pneumatic compression pump
  • Limb volume
  • Lymphatic
  • Lymphedema
  • Management
  • Manual lymphatic drainage
  • Practices
  • Risk reduction
  • Surveillance

ASJC Scopus subject areas

  • Oncology

Cite this

Best-practice guidelines in assessment, risk reduction, management, and surveillance for post-breast cancer lymphedema. / Armer, Jane M.; Hulett, Jennifer M.; Bernas, Michael J; Ostby, Pam; Stewart, Bob R.; Cormier, Janice N.

In: Current Breast Cancer Reports, Vol. 5, No. 2, 06.2013, p. 134-144.

Research output: Contribution to journalArticle

Armer, Jane M. ; Hulett, Jennifer M. ; Bernas, Michael J ; Ostby, Pam ; Stewart, Bob R. ; Cormier, Janice N. / Best-practice guidelines in assessment, risk reduction, management, and surveillance for post-breast cancer lymphedema. In: Current Breast Cancer Reports. 2013 ; Vol. 5, No. 2. pp. 134-144.
@article{d69a48b8205b425b91a42e9032d8b8f2,
title = "Best-practice guidelines in assessment, risk reduction, management, and surveillance for post-breast cancer lymphedema",
abstract = "Breast cancer-related lymphedema (LE) is a progressive, chronic disease that affects millions of cancer survivors and primarily results from surgical lymphatic vessel and/or node removal and radiation therapy. Patient support and education in the importance of early detection is essential in helping health care providers detect lymphedema early, when there is the best chance of preventing progression. Improved imaging and surgical techniques have reduced the incidence of LE; however, effective risk-reduction and treatment have historically lacked the level of evidence necessary to standardize effective treatment. The purpose of this article is to report an extensive review of literature, including highlighted multidisciplinary studies within the past 3 years, in order to update best-practice guidelines in assessment, risk reduction, management, and surveillance for post-breast cancer lymphedema.",
keywords = "Breast cancer, Combined decongestive therapy, Complementary, Compression garment, Exercise, Intermittent pneumatic compression pump, Limb volume, Lymphatic, Lymphedema, Management, Manual lymphatic drainage, Practices, Risk reduction, Surveillance",
author = "Armer, {Jane M.} and Hulett, {Jennifer M.} and Bernas, {Michael J} and Pam Ostby and Stewart, {Bob R.} and Cormier, {Janice N.}",
year = "2013",
month = "6",
doi = "10.1007/s12609-013-0105-0",
language = "English (US)",
volume = "5",
pages = "134--144",
journal = "Current Breast Cancer Reports",
issn = "1943-4588",
publisher = "Current Science, Inc.",
number = "2",

}

TY - JOUR

T1 - Best-practice guidelines in assessment, risk reduction, management, and surveillance for post-breast cancer lymphedema

AU - Armer, Jane M.

AU - Hulett, Jennifer M.

AU - Bernas, Michael J

AU - Ostby, Pam

AU - Stewart, Bob R.

AU - Cormier, Janice N.

PY - 2013/6

Y1 - 2013/6

N2 - Breast cancer-related lymphedema (LE) is a progressive, chronic disease that affects millions of cancer survivors and primarily results from surgical lymphatic vessel and/or node removal and radiation therapy. Patient support and education in the importance of early detection is essential in helping health care providers detect lymphedema early, when there is the best chance of preventing progression. Improved imaging and surgical techniques have reduced the incidence of LE; however, effective risk-reduction and treatment have historically lacked the level of evidence necessary to standardize effective treatment. The purpose of this article is to report an extensive review of literature, including highlighted multidisciplinary studies within the past 3 years, in order to update best-practice guidelines in assessment, risk reduction, management, and surveillance for post-breast cancer lymphedema.

AB - Breast cancer-related lymphedema (LE) is a progressive, chronic disease that affects millions of cancer survivors and primarily results from surgical lymphatic vessel and/or node removal and radiation therapy. Patient support and education in the importance of early detection is essential in helping health care providers detect lymphedema early, when there is the best chance of preventing progression. Improved imaging and surgical techniques have reduced the incidence of LE; however, effective risk-reduction and treatment have historically lacked the level of evidence necessary to standardize effective treatment. The purpose of this article is to report an extensive review of literature, including highlighted multidisciplinary studies within the past 3 years, in order to update best-practice guidelines in assessment, risk reduction, management, and surveillance for post-breast cancer lymphedema.

KW - Breast cancer

KW - Combined decongestive therapy

KW - Complementary

KW - Compression garment

KW - Exercise

KW - Intermittent pneumatic compression pump

KW - Limb volume

KW - Lymphatic

KW - Lymphedema

KW - Management

KW - Manual lymphatic drainage

KW - Practices

KW - Risk reduction

KW - Surveillance

UR - http://www.scopus.com/inward/record.url?scp=84879090862&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879090862&partnerID=8YFLogxK

U2 - 10.1007/s12609-013-0105-0

DO - 10.1007/s12609-013-0105-0

M3 - Article

VL - 5

SP - 134

EP - 144

JO - Current Breast Cancer Reports

JF - Current Breast Cancer Reports

SN - 1943-4588

IS - 2

ER -